The Subcutaneous Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Subcutaneous Drug Delivery Devices Market?
The global market for subcutaneous drug delivery devices has seen substantial growth recently. The market size is projected to expand from $27.66 billion in 2024 to $29.77 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Subcutaneous Drug Delivery Devices Industry?
The Subcutaneous Drug Delivery Devices Global Market is predicted to reach a market size of $39.57 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Subcutaneous Drug Delivery Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Subcutaneous Drug Delivery Devices Market?
The key drivers in the subcutaneous drug delivery devices market are:
• Growth in the biologics and biosimilars market
• Rising adoption of wearable drug delivery systems
• Expansion of personalized medicine
• Improving healthcare reimbursement policies
• Growing emphasis on home healthcare
• Integration of digital health technologies
• Development of smart and connected devices
• Rise of minimally invasive procedures
• Advancements in needle-free injection systems
• Emergence of artificial intelligence in device development.
Global Market Segmentation: Identifying Major Subcutaneous Drug Delivery Devices Industry Segments
The subcutaneous drug delivery devicesmarket covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Pre-order the 2025 Subcutaneous Drug Delivery Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Subcutaneous Drug Delivery Devices Market?
The key trends in the subcutaneous drug delivery devices market are:
• Integration of digital health technologies is a key trend in the subcutaneous drug delivery devices market.
• Development of smart and connected devices is a significant emerging trend.
• There is a rising trend of minimally invasive procedures.
• Advancements in needle-free injection systems and the emergence of artificial intelligence in device development are shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Subcutaneous Drug Delivery Devices Market?
Major companies in the subcutaneous drug delivery devices market are:
• Pfizer Inc.
• Sanofi S.A.
• Roche Holdings Inc.
• Medtronic plc
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Becton Dickinson and Company
• West Pharmaceutical Services Inc.
• Gerresheimer AG
• Insulet Corporation
• SHL Medical AG
• Tandem Diabetes Care Inc.
• Ypsomed Holding AG
• Nemera
• Elcam Medical Ltd.
• Owen Mumford Ltd.
• Haselmeier GmbH
• Sensile Medical AG
• Enable Injections Inc.
• Unilife Corporation
• PharmaJet
• Oval Medical Technologies Ltd.
Regional Dominance: Which Area Leads the Global Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024
